1700025F22Rik Inhibitors encompass compounds that are capable of modulating the activity of the protein encoded by the gene 1700025F22Rik. The inhibitors in this class cover a range of chemical structures and properties, each designed to interact with the protein in a specific manner. These chemicals can act through various mechanisms, such as binding directly to the protein, altering its structural conformation, or modulating its interaction with other cellular components. The diversity in their action is a reflection of the complex nature of protein functions and cellular biochemical networks. The inhibitors can target different aspects of the protein's activity, depending on its role in cellular processes, such as signaling pathways, metabolic regulation, or interactions with DNA, RNA, or other proteins.
The development of these inhibitors represents a significant scientific effort, incorporating molecular biology, chemistry, and computational biology. Researchers use advanced computational methods to model the structure of the protein and predict potential binding sites for inhibitors. Synthetic chemistry is crucial in designing and producing these compounds, which can range from small, targeted molecules to larger, more complex structures. Experimental validation, involving biochemical assays and cellular studies, determines the actual impact of these inhibitors on the protein's function. This exploration contributes to understanding the specific protein and enhances broader knowledge in cellular biochemistry and molecular biology. The study of these inhibitors offers insights into the complex interactions within cells, advancing our understanding of the intricate networks that govern cellular functions.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Kinase inhibitor, can affect phosphorylation processes in signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, can impact PI3K/Akt signaling pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, can affect cell growth and autophagy pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor, can alter gene expression and chromatin remodeling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MAPK/ERK pathway inhibitor, can affect cell signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, can impact stress response and inflammatory signals. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, can impact stress response and apoptosis pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor, can affect various signaling pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, can influence protein degradation processes. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Calcium channel blocker, can affect calcium signaling. | ||||||